Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet

Links shared publicly online about this topic.

  • 737
    total visits

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet

thelancet.com

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised tria...

View full resource at thelancet.com

Tags: Alzheimer's Disease Medication, Schizophrenia Medication, Antipsychotic Medication, Exelon, Haldol, Mortality

  • Share

Most Recently Shared on November 10, 2010 at 7:29 pm By:

palmd PalMD

Study of Exelon in hosp. delirium stopped due to excess mortality http://bit.ly/adSLBf http://www.thelancet.com/

2 years ago...

Psychiatry Article | Haloperidol Mortality

mdlinx.com — “Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: A multicentre, double-blind, placebo-controlled randomised trialView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 12:16 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality i... http://bit.ly/aRmAxm #PSY

2 years ago...

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet

thelancet.com — “Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised tria...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 7:52 am By:

TheLancet The Lancet Medical Journal

We have published a study showing Rivastigmine does not decrease delirium and might increase mortality in critical care http://bit.ly/9oD61a

2 years ago...

Advertisement